Mercuri A - Search Results

1

Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data.

Vardakou M, Mercuri A, Barker SA, Craig DQ, Faulks RM, Wickham MS. Vardakou M, et al. Among authors: mercuri a. AAPS PharmSciTech. 2011 Jun;12(2):620-6. doi: 10.1208/s12249-011-9616-z. Epub 2011 May 10. AAPS PharmSciTech. 2011. PMID: 21557037 Free PMC article. No abstract available.

2

Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.

Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM. Vardakou M, et al. Among authors: mercuri a. Int J Pharm. 2011 Oct 31;419(1-2):192-9. doi: 10.1016/j.ijpharm.2011.07.046. Epub 2011 Aug 9. Int J Pharm. 2011. PMID: 21843611

3

The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study.

Mercuri A, Passalacqua A, Wickham MS, Faulks RM, Craig DQ, Barker SA. Mercuri A, et al. Pharm Res. 2011 Jul;28(7):1540-51. doi: 10.1007/s11095-011-0387-8. Epub 2011 Feb 24. Pharm Res. 2011. PMID: 21347568

4

Identification and molecular interpretation of the effects of drug incorporation on the self-emulsification process using spectroscopic, micropolarimetric and microscopic measurements.

Mercuri A, Belton PS, Royall PG, Barker SA. Mercuri A, et al. Mol Pharm. 2012 Sep 4;9(9):2658-68. doi: 10.1021/mp300219h. Epub 2012 Aug 22. Mol Pharm. 2012. PMID: 22913291

Addition of a drug to a self-emulsifying drug delivery system (SEDDS) can affect the emulsification process after administration, leading to variation in the emulsion droplet size formed and potentially its clinical behavior (Mercuri et al., Pharm. ...However …

Addition of a drug to a self-emulsifying drug delivery system (SEDDS) can affect the emulsification process after administrati …

5

Self-emulsification of Lipidic Drug Delivery System in Pure Water and in Concentrated Glycerol Solution.

Planchette C, Mercuri A, Arcangeli L, Kriechbaum M, Laggner P. Planchette C, et al. Among authors: mercuri a. AAPS PharmSciTech. 2017 Nov;18(8):3053-3063. doi: 10.1208/s12249-017-0785-2. Epub 2017 May 17. AAPS PharmSciTech. 2017. PMID: 28516413

6

An in vitro-in vivo correlation study for nifedipine immediate release capsules administered with water, alcoholic and non-alcoholic beverages: Impact of in vitro dissolution media and hydrodynamics.

Mercuri A, Fares R, Bresciani M, Fotaki N. Mercuri A, et al. Int J Pharm. 2016 Feb 29;499(1-2):330-342. doi: 10.1016/j.ijpharm.2015.12.047. Epub 2015 Dec 22. Int J Pharm. 2016. PMID: 26721731

7

Understanding and predicting the impact of critical dissolution variables for nifedipine immediate release capsules by multivariate data analysis.

Mercuri A, Pagliari M, Baxevanis F, Fares R, Fotaki N. Mercuri A, et al. Int J Pharm. 2017 Feb 25;518(1-2):41-49. doi: 10.1016/j.ijpharm.2016.12.034. Epub 2016 Dec 20. Int J Pharm. 2017. PMID: 28011342

8

In vitro and in silico characterisation of Tacrolimus released under biorelevant conditions.

Mercuri A, Wu S, Stranzinger S, Mohr S, Salar-Behzadi S, Bresciani M, Fröhlich E. Mercuri A, et al. Int J Pharm. 2016 Dec 30;515(1-2):271-280. doi: 10.1016/j.ijpharm.2016.10.020. Epub 2016 Oct 11. Int J Pharm. 2016. PMID: 27737809

9

An in vitro and in silico study of the impact of engineered surface modifications on drug detachment from model carriers.

Wu S, Zellnitz S, Mercuri A, Salar-Behzadi S, Bresciani M, Fröhlich E. Wu S, et al. Among authors: mercuri a. Int J Pharm. 2016 Nov 20;513(1-2):109-117. doi: 10.1016/j.ijpharm.2016.08.064. Epub 2016 Aug 31. Int J Pharm. 2016. PMID: 27592196

10

Effect of the pulmonary deposition and in vitro permeability on the prediction of plasma levels of inhaled budesonide formulation.

Salar-Behzadi S, Wu S, Mercuri A, Meindl C, Stranzinger S, Fröhlich E. Salar-Behzadi S, et al. Among authors: mercuri a. Int J Pharm. 2017 Oct 30;532(1):337-344. doi: 10.1016/j.ijpharm.2017.08.124. Epub 2017 Sep 7. Int J Pharm. 2017. PMID: 28890175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page